Frankfurt: Neurons and blood vessels often traverse the body side by side, a fact observed as early as the 16th
century by the Flemish anatomist Andreas Vesalius. Only over the last
ten years, however, researchers have discovered that the growth of
neuronal and vascular networks is controlled by the same molecules.
Prof. Amparo Acker-Palmer, a pioneer in this area, performs
groundbreaking research on the communication between neurons and blood
vessel cells in the brain. She hopes to use her findings to gain
important insights into brain diseases such as dementia and mental
illness. The European Research Council will fund her project with an
Advanced Investigator Grant of 2.5 million Euros over the next five
years.
“Most interesting is the interaction between neurons and blood
vessels in the cerebral cortex. To date, we know very little about how
neurons communicate with endothelial cells in order to structure a
functional network in the brain.” explains Acker-Palmer. She plans to
assess these processes in the layering of the cerebral cortex during
embryonic development. Here, neuronal cells migrate in an inside out
manner, while blood vessels grow in the opposite direction, from the
pial surface towards the ventricular surface. Since these two growth
processes are coordinated, Acker-Palmer suspects that they are
controlled by the same signaling molecules. How dysfunction in the
crosstalk may lead to cognitive impairments is one of the focuses of her
research.
As model organisms her team uses genetically altered mice and
zebrafish. Translucent zebrafish are the best suitable vertebrate model
to visualize in vivo the dynamic events of cell-to-cell communication at
the neurovascular interface. High-resolution electron microscopes will
also be used to study these close connections between endothelial cells
in the blood capillaries and glial cells at the blood-brain barrier.
Glial cells wrap around the blood capillaries and prevent harmful
substances from the blood stream from entering the brain.. Acker-Palmer
and her team aim at deciphering the molecular signaling pathways
regulating the neurovascular interface. “If we can intervene in the
mechanism and temporarily open the blood-brain barrier, we can insert
active agents and find new approaches for treating dementia and mental
illness,” says the neurobiologist.